MDMA-Assisted Psychotherapy Training
Naropa University was pleased to offer a course in MDMA-assisted psychotherapy in 2020. This training included the MDMA-assisted psychotherapy curriculum developed by MAPS PBC (Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation), together with training in contemplative psychotherapy from Naropa faculty in the Graduate School of Counseling Psychology.
MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics prioritizing public benefit above profit. Founded in 2014, MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS) a 501(c)(3) nonprofit.
The Naropa cohort of trainees brought together 50 therapists from diverse backgrounds across the United States, Canada, Chile and Somalia. Due to Covid, Part B of this training, which usually happens in a retreat setting, was held online. This allowed trainees from all over the world to join the cohort and we look forward to bringing this group through the full protocol. The FDA has suggested that MDMA will be approved by 2023.
This course was offered by MAPS PBC Trainers Marcela Ot’alora G. and Bruce Poulter with Sara Lewis and Lauren Casalino, Naropa University faculty in the Graduate School of Counseling Psychology. Trainees who successfully completed all course assignments can apply their experience for credit for Part A and B of the MDMA Therapy Training Program operated by MAPS Public Benefit Corporation; this cohort is now eligible to move to Part C & D of the training, which we anticipate offering in the coming year. Certification with the MAPS PBC MDMA Therapy Training Program is dependent on passing evaluation of therapist competencies, completion of supervised clinical work in an approved setting, and final supervision evaluation.